167 related articles for article (PubMed ID: 12379847)
1. Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas.
Heaney AP; Fernando M; Yong WH; Melmed S
Nat Med; 2002 Nov; 8(11):1281-7. PubMed ID: 12379847
[TBL] [Abstract][Full Text] [Related]
2. No effect of the PPAR-gamma agonist rosiglitazone on ACTH or cortisol secretion in Nelson's syndrome and Cushing's disease in vitro and in vivo.
Kreutzer J; Jeske I; Hofmann B; Blumcke I; Fahlbusch R; Buchfelder M; Buslei R
Clin Neuropathol; 2009; 28(6):430-9. PubMed ID: 19919817
[TBL] [Abstract][Full Text] [Related]
3. Novel pituitary ligands: peroxisome proliferator activating receptor-gamma.
Heaney AP
Pituitary; 2003; 6(3):153-9. PubMed ID: 14971739
[TBL] [Abstract][Full Text] [Related]
4. PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.
Heaney AP; Fernando M; Melmed S
J Clin Invest; 2003 May; 111(9):1381-8. PubMed ID: 12727930
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone, PPAR-gamma receptor ligand, decreases the viability of rat prolactin-secreting pituitary tumor cells in vitro.
Gruszka A; Kunert-Radek J; Pawlikowski M
Neuro Endocrinol Lett; 2005 Feb; 26(1):51-4. PubMed ID: 15726020
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid prevents experimental Cushing syndrome.
Páez-Pereda M; Kovalovsky D; Hopfner U; Theodoropoulou M; Pagotto U; Uhl E; Losa M; Stalla J; Grübler Y; Missale C; Arzt E; Stalla GK
J Clin Invest; 2001 Oct; 108(8):1123-31. PubMed ID: 11602619
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
8. [Distribution and expression of peroxisome proliferator activated receptor gamma in human pituitary adenomas].
Ma Y; Xia XW; Su CB; Kong YG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):375-7. PubMed ID: 16900637
[TBL] [Abstract][Full Text] [Related]
9. Role of the PPAR-γ system in normal and tumoral pituitary corticotropic cells and adrenal cells.
Mannelli M; Cantini G; Poli G; Mangoni M; Nesi G; Canu L; Rapizzi E; Borgogni E; Ercolino T; Piccini V; Luconi M
Neuroendocrinology; 2010; 92 Suppl 1():23-7. PubMed ID: 20829614
[TBL] [Abstract][Full Text] [Related]
10. The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome.
de Keyzer Y; Lenne F; Auzan C; Jégou S; René P; Vaudry H; Kuhn JM; Luton JP; Clauser E; Bertagna X
J Clin Invest; 1996 Mar; 97(5):1311-8. PubMed ID: 8636444
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma inhibits cellular proliferation and ACTH production in corticotroph tumor cells through a novel janus kinases-signal transducer and activator of transcription 1/nuclear factor-kappa B inhibitory signaling pathway.
Labeur M; Refojo D; Wölfel B; Stalla J; Vargas V; Theodoropoulou M; Buchfelder M; Paez-Pereda M; Arzt E; Stalla GK
J Endocrinol; 2008 Nov; 199(2):177-89. PubMed ID: 18715881
[TBL] [Abstract][Full Text] [Related]
12. Purinergic receptor ligands stimulate pro-opiomelanocortin gene expression in AtT-20 pituitary corticotroph cells.
Zhao LF; Iwasaki Y; Oki Y; Tsugita M; Taguchi T; Nishiyama M; Takao T; Kambayashi M; Hashimoto K
J Neuroendocrinol; 2006 Apr; 18(4):273-8. PubMed ID: 16503922
[TBL] [Abstract][Full Text] [Related]
13. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.
Winczyk K; Kunert-Radek J; Gruszka A; Radek M; Ławnicka H; Pawlikowski M
Neuro Endocrinol Lett; 2009 Mar; 30(1):107-10. PubMed ID: 19300395
[TBL] [Abstract][Full Text] [Related]
14. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
[TBL] [Abstract][Full Text] [Related]
15. EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.
Fukuoka H; Cooper O; Ben-Shlomo A; Mamelak A; Ren SG; Bruyette D; Melmed S
J Clin Invest; 2011 Dec; 121(12):4712-21. PubMed ID: 22105169
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease.
Ambrosi B; Dall'Asta C; Cannavo S; Libe R; Vigo T; Epaminonda P; Chiodini I; Ferrero S; Trimarchi F; Arosio M; Beck-Peccoz P
Eur J Endocrinol; 2004 Aug; 151(2):173-8. PubMed ID: 15296471
[TBL] [Abstract][Full Text] [Related]
17. PPAR-gamma in Cushing's disease.
Heaney AP
Pituitary; 2004; 7(4):265-9. PubMed ID: 16416039
[TBL] [Abstract][Full Text] [Related]
18. Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function.
Gentilin E; Tagliati F; Terzolo M; Zoli M; Lapparelli M; Minoia M; Ambrosio MR; Degli Uberti EC; Zatelli MC
J Endocrinol; 2013 Sep; 218(3):275-85. PubMed ID: 23814013
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma in the human pituitary gland: expression and splicing pattern in adenomas versus normal pituitary.
Occhi G; Albiger N; Berlucchi S; Gardiman M; Scanarini M; Scienza R; Fassina A; Mantero F; Scaroni C
J Neuroendocrinol; 2007 Jul; 19(7):552-9. PubMed ID: 17561883
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
Kim EJ; Park KS; Chung SY; Sheen YY; Moon DC; Song YS; Kim KS; Song S; Yun YP; Lee MK; Oh KW; Yoon DY; Hong JT
J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
